165 related articles for article (PubMed ID: 22058145)
1. Risk modification of colorectal adenoma by CYP7A1 polymorphisms and the role of bile acid metabolism in carcinogenesis.
Wertheim BC; Smith JW; Fang C; Alberts DS; Lance P; Thompson PA
Cancer Prev Res (Phila); 2012 Feb; 5(2):197-204. PubMed ID: 22058145
[TBL] [Abstract][Full Text] [Related]
2. Gender, but not CYP7A1 or SLCO1B1 polymorphism, affects the fasting plasma concentrations of bile acids in human beings.
Xiang X; Backman JT; Neuvonen PJ; Niemi M
Basic Clin Pharmacol Toxicol; 2012 Mar; 110(3):245-52. PubMed ID: 21902813
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphism of cholesterol 7alpha-hydroxylase (CYP7A1) and colorectal adenomas: Self Defense Forces Health Study.
Tabata S; Yin G; Ogawa S; Yamaguchi K; Mineshita M; Kono S
Cancer Sci; 2006 May; 97(5):406-10. PubMed ID: 16630139
[TBL] [Abstract][Full Text] [Related]
4. Effects of ursodeoxycholic acid on the gut microbiome and colorectal adenoma development.
Pearson T; Caporaso JG; Yellowhair M; Bokulich NA; Padi M; Roe DJ; Wertheim BC; Linhart M; Martinez JA; Bilagody C; Hornstra H; Alberts DS; Lance P; Thompson PA
Cancer Med; 2019 Feb; 8(2):617-628. PubMed ID: 30652422
[TBL] [Abstract][Full Text] [Related]
5. Association between Circulating Vitamin D Metabolites and Fecal Bile Acid Concentrations.
Jacobs ET; Haussler MR; Alberts DS; Kohler LN; Lance P; Martínez ME; Roe DJ; Jurutka PW
Cancer Prev Res (Phila); 2016 Jul; 9(7):589-97. PubMed ID: 27138789
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor 1498C/T, 936C/T polymorphisms associated with increased risk of colorectal adenoma: a Chinese case-control study.
Wu X; Li D; Liu Z; Wan X; Wu Y; Jiang C; Qian Q
Mol Biol Rep; 2011 Mar; 38(3):1949-55. PubMed ID: 20857215
[TBL] [Abstract][Full Text] [Related]
7. Changes in bile acid composition and effect on cytolytic activity of fecal water by ursodeoxycholic acid administration: a placebo-controlled cross-over intervention trial in healthy volunteers.
van Gorkom BA; van der Meer R; Boersma-van Ek W; Termont DS; de Vries EG; Kleibeuker JH
Scand J Gastroenterol; 2002 Aug; 37(8):965-71. PubMed ID: 12229974
[TBL] [Abstract][Full Text] [Related]
8. The effect of ursodeoxycholic acid on the relative expression of the lipid metabolism genes in mouse cholesterol gallstone models.
Fan N; Meng K; Zhang Y; Hu Y; Li D; Gao Q; Wang J; Li Y; Wu S; Cui Y
Lipids Health Dis; 2020 Jul; 19(1):158. PubMed ID: 32615989
[TBL] [Abstract][Full Text] [Related]
9. Gender modifies the effect of ursodeoxycholic acid in a randomized controlled trial in colorectal adenoma patients.
Thompson PA; Wertheim BC; Roe DJ; Ashbeck EL; Jacobs ET; Lance P; Martínez ME; Alberts DS
Cancer Prev Res (Phila); 2009 Dec; 2(12):1023-30. PubMed ID: 19952360
[TBL] [Abstract][Full Text] [Related]
10. Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence.
Alberts DS; Martínez ME; Hess LM; Einspahr JG; Green SB; Bhattacharyya AK; Guillen J; Krutzsch M; Batta AK; Salen G; Fales L; Koonce K; Parish D; Clouser M; Roe D; Lance P;
J Natl Cancer Inst; 2005 Jun; 97(11):846-53. PubMed ID: 15928305
[TBL] [Abstract][Full Text] [Related]
11. CYP7A1 (-204 A>C; rs3808607 and -469 T>C; rs3824260) promoter polymorphisms and risk of gallbladder cancer in North Indian population.
Srivastava A; Choudhuri G; Mittal B
Metabolism; 2010 Jun; 59(6):767-73. PubMed ID: 20005541
[TBL] [Abstract][Full Text] [Related]
12. Linkage disequilibrium blocks, haplotype structure, and htSNPs of human CYP7A1 gene.
Nakamoto K; Wang S; Jenison RD; Guo GL; Klaassen CD; Wan YJ; Zhong XB
BMC Genet; 2006 May; 7():29. PubMed ID: 16709249
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphism in cytochrome P450 7A1 and risk of colorectal cancer: the Fukuoka Colorectal Cancer Study.
Hagiwara T; Kono S; Yin G; Toyomura K; Nagano J; Mizoue T; Mibu R; Tanaka M; Kakeji Y; Maehara Y; Okamura T; Ikejiri K; Futami K; Yasunami Y; Maekawa T; Takenaka K; Ichimiya H; Imaizumi N
Cancer Res; 2005 Apr; 65(7):2979-82. PubMed ID: 15805302
[TBL] [Abstract][Full Text] [Related]
14. Results of a phase I multiple-dose clinical study of ursodeoxycholic Acid.
Hess LM; Krutzsch MF; Guillen J; Chow HH; Einspahr J; Batta AK; Salen G; Reid ME; Earnest DL; Alberts DS
Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):861-7. PubMed ID: 15159320
[TBL] [Abstract][Full Text] [Related]
15. Ursodeoxycholic acid therapy and the risk of colorectal adenoma in patients with primary biliary cirrhosis: an observational study.
Serfaty L; De Leusse A; Rosmorduc O; Desaint B; Flejou JF; Chazouilleres O; Poupon RE; Poupon R
Hepatology; 2003 Jul; 38(1):203-9. PubMed ID: 12830003
[TBL] [Abstract][Full Text] [Related]
16. Correlation of farnesoid X receptor coactivator recruitment and cholesterol 7alpha-hydroxylase gene repression by bile acids.
Bramlett KS; Yao S; Burris TP
Mol Genet Metab; 2000 Dec; 71(4):609-15. PubMed ID: 11136553
[TBL] [Abstract][Full Text] [Related]
17. Cholesterol feeding of mice expressing cholesterol 7alpha-hydroxylase increases bile acid pool size despite decreased enzyme activity.
Tiemann M; Han Z; Soccio R; Bollineni J; Shefer S; Sehayek E; Breslow JL
Proc Natl Acad Sci U S A; 2004 Feb; 101(7):1846-51. PubMed ID: 14762172
[TBL] [Abstract][Full Text] [Related]
18. Alternate pathways of bile acid synthesis in the cholesterol 7alpha-hydroxylase knockout mouse are not upregulated by either cholesterol or cholestyramine feeding.
Schwarz M; Russell DW; Dietschy JM; Turley SD
J Lipid Res; 2001 Oct; 42(10):1594-603. PubMed ID: 11590215
[TBL] [Abstract][Full Text] [Related]
19. Association of genes involved in bile acid synthesis with the progression of primary biliary cirrhosis in Japanese patients.
Inamine T; Higa S; Noguchi F; Kondo S; Omagari K; Yatsuhashi H; Tsukamoto K; Nakamura M
J Gastroenterol; 2013 Oct; 48(10):1160-70. PubMed ID: 23354620
[TBL] [Abstract][Full Text] [Related]
20. Barley β-glucan reduces blood cholesterol levels via interrupting bile acid metabolism.
Wang Y; Harding SV; Thandapilly SJ; Tosh SM; Jones PJH; Ames NP
Br J Nutr; 2017 Nov; 118(10):822-829. PubMed ID: 29115200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
